Basilea Pharmaceutica AG (BSLN) — Capital Reinvestment Ratio
Basilea Pharmaceutica AG (BSLN) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (CHF39.03 Million) in capital expenditures (CHF2.30 Million). See net asset quality index of Basilea Pharmaceutica AG to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Basilea Pharmaceutica AG Capital Reinvestment Ratio (2005–2025)
This chart tracks Basilea Pharmaceutica AG's Capital Reinvestment Ratio across 8 annual periods. Check Basilea Pharmaceutica AG cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Basilea Pharmaceutica AG (2005–2025)
Year-by-year Capital Reinvestment Ratio for Basilea Pharmaceutica AG from 2005 to 2025. For live market cap and broader valuation context, see how much is Basilea Pharmaceutica AG worth.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CHF62.09 Million | CHF2.62 Million | ▲ +83.5% |
| 2024 | 0.02x | CHF74.36 Million | CHF1.71 Million | ▼ -68.3% |
| 2023 | 0.07x | CHF14.24 Million | CHF1.03 Million | ▼ -84.5% |
| 2022 | 0.47x | CHF7.06 Million | CHF3.30 Million | ▲ +1151.9% |
| 2017 | 0.04x | CHF19.01 Million | CHF711.00K | ▲ +319.3% |
| 2012 | 0.01x | CHF148.17 Million | CHF1.32 Million | ▼ -23.3% |
| 2010 | 0.01x | CHF106.64 Million | CHF1.24 Million | ▼ -66.7% |
| 2005 | 0.03x | CHF34.38 Million | CHF1.20 Million | — |